Oculis Holding AG Ordinary shares
Price & Volume
Stats
See moreOpen | $17.50 |
Previous Close | $17.75 |
Day Range | $17.50-$17.75 |
52W Range | $11.91-$23.08 |
Market Cap | $927.9M |
Shares Short | 11,685 |
Financials
See moreRevenue (12 Mos) | $764,000 |
Revenue Growth (YoY) | 6.5% |
Gross Profit (12 Mos) | -$53.6M |
Diluted EPS | -$2.92 |
News
See moreYahoo Finance • 3 days ago
Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
Yahoo Finance • 21 days ago
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
Yahoo Finance • 24 days ago
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
Yahoo Finance • 27 days ago
Citi initiates Lumentum coverage with Buy, citing AI optics leadership
About
CEO | Dr. Riad Sherif M.B.A., M.D. |
Address | Bahnhofstrasse 20, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 49 |
